Log in

Pacira Biosciences Earnings Date, Estimates & History (NASDAQ:PCRX)

+0.03 (+0.07 %)
(As of 11/14/2019 03:31 AM ET)
Today's Range
Now: $42.87
50-Day Range
MA: $39.70
52-Week Range
Now: $42.87
Volume318,700 shs
Average Volume627,915 shs
Market Capitalization$1.78 billion
P/E Ratio147.83
Dividend YieldN/A


Pacira Biosciences (NASDAQ:PCRX) Earnings Information

Pacira Biosciences last posted its earnings data on November 7th, 2019. The reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.35. The company earned $104.69 million during the quarter, compared to analysts' expectations of $104.88 million. Its revenue was up 25.5% on a year-over-year basis. Pacira Biosciences has generated $0.29 earnings per share over the last year and currently has a price-to-earnings ratio of 147.8. Pacira Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2020 based off prior year's report dates.

Pacira Biosciences Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Pacira Biosciences (NASDAQ:PCRX) Earnings Estimates

2019 EPS Consensus Estimate: $0.61
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20192($0.02)$0.15$0.07
Q2 20192$0.02$0.14$0.08
Q3 20193$0.07$0.21$0.14
Q4 20193$0.22$0.39$0.32

Pacira Biosciences (NASDAQ PCRX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/7/2019Q3 2019$0.13$0.48$0.67$104.88 million$104.69 millionTranscript
8/8/2019Q2 2019$0.14$0.41$0.40$99.92 million$102.60 millionListen
5/2/20193/31/2019$0.02$0.22$0.15$92.13 million$91.31 millionN/A
2/28/2019Q4 2018$0.07$0.28$0.36$93.69 million$95.12 millionN/A
11/1/20189/30/2018($0.09)$0.31$0.24$79.87 million$83.45 millionListen
8/2/2018Q2 2018($0.13)$0.24$0.08$77.53 million$84.10 millionN/A
5/3/2018Q1 2018$0.02$0.02($0.10)$73.92 million$74.61 millionN/A
2/28/2018Q4 2017($0.08)$0.38$0.25$79.06 million$79.08 millionN/A
11/8/2017Q3 2017($0.04)$0.11($0.03)$68.99 million$67.30 millionN/A
8/2/2017Q2 2017($0.05)($0.11)($0.09)$73.37 million$70.90 millionListen
5/4/2017Q1 2017($0.23)($0.19)($0.24)$70.30 million$69.30 millionListen
3/1/2017Q4 2016($0.15)($0.12)($0.13)$73.08 million$72.90 millionListen
11/2/2016Q316($0.02)$0.20$67.16 million$68.40 millionListen
8/4/2016Q2 2016($0.20)($0.02)$0.17$67.80 million$69.60 millionListen
5/2/2016Q1 2016($0.10)($0.08)($0.06)$67.11 million$65.50 millionListen
2/25/2016Q4 2015$0.04($0.04)($0.01)$68.40 million$69.30 millionListen
10/27/2015Q3 2015$0.03$0.10$0.12$60.44 million$62.20 millionListen
7/30/2015Q2 2015$0.04$0.03$0.06$62.97 million$59.10 millionListen
4/30/2015Q1 2015$0.02$0.05$0.07$61.11 million$58.30 millionListen
2/24/2015Q4 2014$0.19$0.16$0.18$61.62 million$61.80 millionListen
10/30/2014Q3 2014($0.01)($0.05)($0.02)$52.20 million$52.00 millionListen
7/31/2014Q2 2014($0.24)($0.11)($0.08)$42.20 million$47.20 millionListen
5/1/2014Q1 2014($0.30)($0.31)($0.28)$35.40 million$36.70 millionListen
2/25/2014Q4 2013($0.31)($0.33)($0.30)$30.72 million$33.56 millionListen
10/31/2013Q3 2013($0.36)($0.41)($0.38)$22.10 million$23.30 millionListen
8/6/2013Q2 2013($0.43)($0.42)($0.42)$16.45 million$17.14 millionN/A
5/8/2013Q1 2013($0.49)($0.61)($0.51)$12.60 million$11.59 millionN/A
3/7/2013Q4 2012($0.41)($0.50)($0.50)N/A
11/1/2012Q312($0.44)($0.49)$7.85 million$8.50 millionN/A
8/9/2012Q2 2012($0.43)($0.27)($0.27)N/A
5/9/2012Q1 2012($0.39)($0.47)($0.47)N/A
3/27/2012Q4 2011($0.54)($0.58)($0.44)N/A
10/31/2011Q3 2011($0.59)($0.55)($0.55)N/A
8/11/2011Q2 2011($0.58)($0.51)($0.51)N/A
5/11/2011Q1 2011($0.53)($0.98)($0.98)N/A
3/31/2011Q4 2010($11.95)($11.63)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 11/14/2019 by MarketBeat.com Staff

Featured Article: What is the balance sheet?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel